142 related articles for article (PubMed ID: 2953634)
1. The fibrinolytic enzyme system in normal menstruation and excessive uterine bleeding and the effect of tranexamic acid.
Dockeray CJ; Sheppard BL; Daly L; Bonnar J
Eur J Obstet Gynecol Reprod Biol; 1987 Apr; 24(4):309-18. PubMed ID: 2953634
[TBL] [Abstract][Full Text] [Related]
2. The effect of tranexamic acid on measured menstrual loss and endometrial fibrinolytic enzymes in dysfunctional uterine bleeding.
Gleeson NC; Buggy F; Sheppard BL; Bonnar J
Acta Obstet Gynecol Scand; 1994 Mar; 73(3):274-7. PubMed ID: 8122512
[TBL] [Abstract][Full Text] [Related]
3. Endometrial fibrinolytic enzymes in women with normal menstruation and dysfunctional uterine bleeding.
Gleeson N; Devitt M; Sheppard BL; Bonnar J
Br J Obstet Gynaecol; 1993 Aug; 100(8):768-71. PubMed ID: 8399019
[TBL] [Abstract][Full Text] [Related]
4. Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid.
Bonnar J; Sheppard BL
BMJ; 1996 Sep; 313(7057):579-82. PubMed ID: 8806245
[TBL] [Abstract][Full Text] [Related]
5. Fibrinolytic activity in utero and bleeding complications with intrauterine contraceptive devices.
Bonnar J; Kasonde K; Haddon M; Hassanein MK; Allington MJ
Br J Obstet Gynaecol; 1976 Feb; 83(2):160-4. PubMed ID: 148902
[TBL] [Abstract][Full Text] [Related]
6. An objective evaluation of flurbiprofen and tranexamic acid in the treatment of idiopathic menorrhagia.
Andersch B; Milsom I; Rybo G
Acta Obstet Gynecol Scand; 1988; 67(7):645-8. PubMed ID: 3073625
[TBL] [Abstract][Full Text] [Related]
7. Comparison between antifibrinolytic and antiprostaglandin treatment in the reduction of increased menstrual blood loss in women with intrauterine contraceptive devices.
Ylikorkala O; Viinikka L
Br J Obstet Gynaecol; 1983 Jan; 90(1):78-83. PubMed ID: 6336951
[TBL] [Abstract][Full Text] [Related]
8. Hemorrhage induced by intrauterine devices: control by local proteinase inhibition.
Tauber PF; Wolf AS; Herting W; Zaneveld LJ
Fertil Steril; 1977 Dec; 28(12):1375-7. PubMed ID: 590549
[TBL] [Abstract][Full Text] [Related]
9. No increased systemic fibrinolysis in women with heavy menstrual bleeding.
Wiewel-Verschueren S; Knol HM; Lisman T; Bogchelman DH; Kluin-Nelemans JC; van der Zee AG; Mulder AB; Meijer K
J Thromb Haemost; 2014 Sep; 12(9):1488-93. PubMed ID: 24954113
[TBL] [Abstract][Full Text] [Related]
10. Uterine artery blood flow parameters in women with dysfunctional uterine bleeding and uterine fibroids: the effects of tranexamic acid.
Lakhani KP; Marsh MS; Purcell W; Hardiman P
Ultrasound Obstet Gynecol; 1998 Apr; 11(4):283-5. PubMed ID: 9618854
[TBL] [Abstract][Full Text] [Related]
11. Non-surgical interventions for treating heavy menstrual bleeding (menorrhagia) in women with bleeding disorders.
Ray S; Ray A
Cochrane Database Syst Rev; 2014 Nov; (11):CD010338. PubMed ID: 25426776
[TBL] [Abstract][Full Text] [Related]
12. Antifibrinolytics for heavy menstrual bleeding.
Lethaby A; Farquhar C; Cooke I
Cochrane Database Syst Rev; 2000; (4):CD000249. PubMed ID: 11034679
[TBL] [Abstract][Full Text] [Related]
13. Fibrinolytic activity of cerebral tissue after experimental subarachnoid haemorrhage: inhibitory effect of tranexamic acid (AMCA).
Fodstad H; Kok P; Algers G
Acta Neurol Scand; 1981 Jul; 64(1):29-46. PubMed ID: 7198859
[TBL] [Abstract][Full Text] [Related]
14. Cyclic changes in endometrial tissue plasminogen activator and plasminogen activator inhibitor type 1 in women with normal menstruation and essential menorrhagia.
Gleeson NC
Am J Obstet Gynecol; 1994 Jul; 171(1):178-83. PubMed ID: 8030696
[TBL] [Abstract][Full Text] [Related]
15. On the correlation between local fibrinolytic activity in menstrual fluid and total blood loss during menstruation and effects of desmopressin.
Edlund M; Blombäck M; He S
Blood Coagul Fibrinolysis; 2003 Sep; 14(6):593-8. PubMed ID: 12960614
[TBL] [Abstract][Full Text] [Related]
16. A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia.
Milsom I; Andersson K; Andersch B; Rybo G
Am J Obstet Gynecol; 1991 Mar; 164(3):879-83. PubMed ID: 1900665
[TBL] [Abstract][Full Text] [Related]
17. Fibrinogen-fibrin degradation products in menstrual blood from women with normal and excessive menstrual losses.
Hahn L; Rybo G
Acta Obstet Gynecol Scand; 1975; 54(2):119-27. PubMed ID: 1136717
[TBL] [Abstract][Full Text] [Related]
18. Treatment of idiopathic menorrhagia with tranexamic acid.
Srinil S; Jaisamrarn U
J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S1-6. PubMed ID: 17722310
[TBL] [Abstract][Full Text] [Related]
19. Tranexamic acid therapy for heavy menstrual bleeding.
Lumsden MA; Wedisinghe L
Expert Opin Pharmacother; 2011 Sep; 12(13):2089-95. PubMed ID: 21767224
[TBL] [Abstract][Full Text] [Related]
20. Antifibrinolytics for heavy menstrual bleeding.
Cooke I; Lethaby A; Farquhar C
Cochrane Database Syst Rev; 2000; (2):CD000249. PubMed ID: 10796518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
